Cargando…
Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
Although rheumatoid arthritis (RA) results in a 50% increased risk of cardiovascular disease mortality, comparable to the risk associated with diabetes mellitus, a significant care gap remains in cardiovascular risk management for this high-risk population. A retrospective cohort study was conducted...
Autores principales: | Aronov, Avi, Kim, Yoo Jin, Sweiss, Nadera J, Nazir, Noreen T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489492/ https://www.ncbi.nlm.nih.gov/pubmed/36157554 http://dx.doi.org/10.1016/j.ajpc.2022.100380 |
Ejemplares similares
-
Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014) -
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010) -
THE IMPACT OF THE COVID-19 PANDEMIC ON ACCESS TO CARDIOVASCULAR CARE LEADING TO INCREASED CARDIOVASCULAR MORTALITY
por: Kim, Yoo Jin, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on cardiovascular disease mortality in a major metropolitan area
por: Kim, Yoo Jin, et al.
Publicado: (2022) -
Patient Perception of Cardiovascular Risk in Rheumatoid Arthritis
por: Banerjee, Shubhasree, et al.
Publicado: (2020)